Cargando…
miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424166/ https://www.ncbi.nlm.nih.gov/pubmed/25486872 http://dx.doi.org/10.1038/leu.2014.344 |
| _version_ | 1782370299393605632 |
|---|---|
| author | Guinn, Daphne Ruppert, Amy S. Maddocks, Kami Jaglowski, Samantha Gordon, Amber Lin, Thomas S. Larson, Richard Marcucci, Guido Hertlein, Erin Woyach, Jennifer Johnson, Amy J. Byrd, John C. |
| author_facet | Guinn, Daphne Ruppert, Amy S. Maddocks, Kami Jaglowski, Samantha Gordon, Amber Lin, Thomas S. Larson, Richard Marcucci, Guido Hertlein, Erin Woyach, Jennifer Johnson, Amy J. Byrd, John C. |
| author_sort | Guinn, Daphne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4424166 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44241662015-11-01 miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. Guinn, Daphne Ruppert, Amy S. Maddocks, Kami Jaglowski, Samantha Gordon, Amber Lin, Thomas S. Larson, Richard Marcucci, Guido Hertlein, Erin Woyach, Jennifer Johnson, Amy J. Byrd, John C. Leukemia Article 2014-12-09 2015-05 /pmc/articles/PMC4424166/ /pubmed/25486872 http://dx.doi.org/10.1038/leu.2014.344 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
| spellingShingle | Article Guinn, Daphne Ruppert, Amy S. Maddocks, Kami Jaglowski, Samantha Gordon, Amber Lin, Thomas S. Larson, Richard Marcucci, Guido Hertlein, Erin Woyach, Jennifer Johnson, Amy J. Byrd, John C. miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title_full | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title_fullStr | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title_full_unstemmed | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title_short | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. |
| title_sort | mir-155 expression is associated with chemoimmunotherapy outcome and is modulated by bruton's tyrosine kinase inhibition with ibrutinib. |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424166/ https://www.ncbi.nlm.nih.gov/pubmed/25486872 http://dx.doi.org/10.1038/leu.2014.344 |
| work_keys_str_mv | AT guinndaphne mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT ruppertamys mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT maddockskami mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT jaglowskisamantha mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT gordonamber mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT linthomass mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT larsonrichard mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT marcucciguido mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT hertleinerin mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT woyachjennifer mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT johnsonamyj mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib AT byrdjohnc mir155expressionisassociatedwithchemoimmunotherapyoutcomeandismodulatedbybrutonstyrosinekinaseinhibitionwithibrutinib |